← Back to Discover

THOMPSON INVESTMENT MANAGEMENT, INC.

Period ended Sep 30, 2026 · Latest filing Oct 14, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Sep 30, 2026: $872,574,636

More quarters will appear as history becomes available.

Top holdings

Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. ALPHABET INC CAP STK CL A · COM · 02079K305 · shares: $45,335,293
  2. MICROSOFT CORP · COM · 594918104 · shares: $39,119,270
  3. EXXONMOBIL HOLDINGS CORP · COM · 30233Q108 · shares: $24,419,105
  4. VIATRIS · COM · 92556V106 · shares: $18,589,358
  5. QUALCOMM INC · COM · 747525103 · shares: $16,821,821
  6. CITIGROUP INC COM NEW · COM · 172967424 · shares: $16,352,758
  7. META PLATFORMS · COM · 30303M102 · shares: $15,070,450
  8. KORNIT DIGITAL LTD SHS · ADR · M6372Q113 · shares: $15,005,434
  9. AMN HEALTHCARE SVCS INC COM · COM · 001744101 · shares: $14,236,776
  10. JPMORGAN CHASE & CO COM · COM · 46625H100 · shares: $13,757,924

Reported holdings

504 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
INOVIO PHARMACEUTICALS INC COMCOM45773H409 — 13 shares $16
ACCESS POWER & CO INCCOM00431N108 — 200 shares $0
Sycamore Partners DAP RightRIGHT255670d65 — 699,402 shares $0
THERAVANCE BIOPHARMA CVRRIGHTg88cvr017 — 3,046 shares $0